Experience in using dipyridamole in the group of pregnant women with a high risk of perinatal pathology

This article provides the evaluation results of the efficacy of low-dose dipyridamole (CurantylÒ) [1, 2] taken to prevent placental insufficiency in women in the group with a high risk of perinatal pathology and feto-maternal disease in past medical history. The early use of low-dose dipyridamole in...

Full description

Bibliographic Details
Main Authors: T. M. Sokolova, I. O. Marinkin, V. M. Kuleshov, K. Yu. Makarov
Format: Article
Language:Russian
Published: Remedium Group LLC 2018-04-01
Series:Медицинский совет
Subjects:
Online Access:https://www.med-sovet.pro/jour/article/view/2414
id doaj-58d08372577b4e38b3c37da7a9516257
record_format Article
spelling doaj-58d08372577b4e38b3c37da7a95162572021-07-28T13:29:35ZrusRemedium Group LLCМедицинский совет2079-701X2658-57902018-04-01079810010.21518/2079-701X-2018-7-98-1002388Experience in using dipyridamole in the group of pregnant women with a high risk of perinatal pathologyT. M. Sokolova0I. O. Marinkin1V. M. Kuleshov2K. Yu. Makarov3Novosibirsk State Medical University of the Ministry of Health of RussiaNovosibirsk State Medical University of the Ministry of Health of RussiaNovosibirsk State Medical University of the Ministry of Health of RussiaNovosibirsk State Medical University of the Ministry of Health of RussiaThis article provides the evaluation results of the efficacy of low-dose dipyridamole (CurantylÒ) [1, 2] taken to prevent placental insufficiency in women in the group with a high risk of perinatal pathology and feto-maternal disease in past medical history. The early use of low-dose dipyridamole in high-risk groups contributes to a significant reduction in the frequency of intrauterine growth retardation, premature labour and birth of low birth-weight babies.https://www.med-sovet.pro/jour/article/view/2414placental insufficiencyintrauterine growth retardationdipyridamole
collection DOAJ
language Russian
format Article
sources DOAJ
author T. M. Sokolova
I. O. Marinkin
V. M. Kuleshov
K. Yu. Makarov
spellingShingle T. M. Sokolova
I. O. Marinkin
V. M. Kuleshov
K. Yu. Makarov
Experience in using dipyridamole in the group of pregnant women with a high risk of perinatal pathology
Медицинский совет
placental insufficiency
intrauterine growth retardation
dipyridamole
author_facet T. M. Sokolova
I. O. Marinkin
V. M. Kuleshov
K. Yu. Makarov
author_sort T. M. Sokolova
title Experience in using dipyridamole in the group of pregnant women with a high risk of perinatal pathology
title_short Experience in using dipyridamole in the group of pregnant women with a high risk of perinatal pathology
title_full Experience in using dipyridamole in the group of pregnant women with a high risk of perinatal pathology
title_fullStr Experience in using dipyridamole in the group of pregnant women with a high risk of perinatal pathology
title_full_unstemmed Experience in using dipyridamole in the group of pregnant women with a high risk of perinatal pathology
title_sort experience in using dipyridamole in the group of pregnant women with a high risk of perinatal pathology
publisher Remedium Group LLC
series Медицинский совет
issn 2079-701X
2658-5790
publishDate 2018-04-01
description This article provides the evaluation results of the efficacy of low-dose dipyridamole (CurantylÒ) [1, 2] taken to prevent placental insufficiency in women in the group with a high risk of perinatal pathology and feto-maternal disease in past medical history. The early use of low-dose dipyridamole in high-risk groups contributes to a significant reduction in the frequency of intrauterine growth retardation, premature labour and birth of low birth-weight babies.
topic placental insufficiency
intrauterine growth retardation
dipyridamole
url https://www.med-sovet.pro/jour/article/view/2414
work_keys_str_mv AT tmsokolova experienceinusingdipyridamoleinthegroupofpregnantwomenwithahighriskofperinatalpathology
AT iomarinkin experienceinusingdipyridamoleinthegroupofpregnantwomenwithahighriskofperinatalpathology
AT vmkuleshov experienceinusingdipyridamoleinthegroupofpregnantwomenwithahighriskofperinatalpathology
AT kyumakarov experienceinusingdipyridamoleinthegroupofpregnantwomenwithahighriskofperinatalpathology
_version_ 1721274034478383104